作者综述了立体定向r后的结果adiosurgery for patients with acromegaly and analyzed factors associated with biochemical remission.
Retrospective analysis was performed for 46 consecutive cases of growth hormone (GH)–producing pituitary adenomas treated by radiosurgery between 1991 and 2004. Biochemical remission was defined as a fasting GH less than 2 ng/ml and a normal age- and sex-adjusted insulin-like growth factor–I (IGF-I) level while patients were not receiving any pituitary suppressive medications. The median follow up after radiosurgery was 63 months (range 22–168 months).
Twenty-three patients (50%) had biochemical remission documented at a median of 36 months (range 6–63 months) after one radiosurgical procedure. The actuarial rates of biochemical remission at 2 and 5 years after radiosurgery were 11 and 60%, respectively. Multivariate analysis showed that IGF-I levels less than 2.25 times the upper limit of normal (hazard ratio [HR] 2.9, 95% confidence interval [CI] 1.2–6.9, p = 0.02) and the absence of pituitary suppressive medications at the time of radiosurgery (HR 4.2, 95% CI 1.4–13.2, p = 0.01) correlated with biochemical remission. The incidence of new anterior pituitary deficits was 10% at 2 years and 33% at 5 years.
Discontinuation of pituitary suppressive medications at least 1 month before radiosurgery significantly improved endocrine outcomes for patients with acromegaly. Patients with GH–producing pituitary adenomas should not undergo further radiation therapy or surgery for at least 5 years after radiosurgery because GH and IGF-I levels continue to normalize over that interval.
AboschA,,TyrrellJB,,LambornKR,,HanneganLT,,AppleburyCB,&WilsonCB:Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.J Clin Endocrinol Metab83:3411–3418,1998
AlexanderMJ,,DeSallesAA,&TomiyasuU:Multiple radiation-induced intracranial lesions after treatment for pituitary adenoma. Case report.J Neurosurg88:111–115,1998
AttanasioR,,EpaminondaP,,MottiE,,GiugniE,,VentrellaL,&CozziR,et al.:Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.J Clin Endocrinol Metab88:3105–3112,2003
BarkanAL,,HalaszI,,DornfeldKJ,,JaffeCA,,FribergRD,&ChandlerWF,et al.:Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.J Clin Endocrinol Metab82:3187–3191,1997
BengtssonBA,,EdenS,,ErnestI,,OdenA,&SjogrenB:Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.Acta Med Scand223:327–335,1988
CastinettiF,,TaiebD,,KuhnJM,,ChansonP,,TamuraM,&JaquetP,et al.:Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion.J Clin Endocrinol Metab90:4483–4488,2005
ConstineLS,,WoolfPD,,CannD,,MickG,,McCormickK,&RaubertasRF,et al.:Hypothalamicpituitary dysfunction after radiation for brain tumors.N Engl J Med328:87–94,1993
CozziR,,BarausseM,,AsnaghiD,,DallabonzanaD,,LodriniS,&AttanasioR:Failure of radiotherapy in acromegaly.Eur J Endocrinol145:717–726,2001
FeigelGC,,BonelliCM,,BergholdA,&MokryM:Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function.J Neurosurg97:5 Suppl415–421,2002
FredaPU,,KatznelsonL,,van der LelyAJ,,ReyesCM,,ZhaoS,&RabinowitzRD:Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.J Clin Endocrinol Metab90:465–4473,2005
FredaPU,,WardlawSL,&PostKD:Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.J Neurosurg89:353–358,1998
Growth Hormone Research Society, Pituitary Society:Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.J Clin Endocrinol Metab89:3099–3102,2004
GuttB,,WowraB,,AlexandrovR,,UhlE,,SchaafL,&StallaGK,et al.:Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.Exp Clin Endocrinol Diabetes113:219–224,2005
HoldawayIM:Treatment of acromegaly.Horm Res62:3 Suppl79–92,2004
IkedaH,,JokuraH,&YoshimotoT:Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma.J Neurosurg95:285–291,2001
LandoltAM,,HallerD,,LomaxN,,ScheibS,,SchubigerO,&SiegfriedJ,et al.:Octreotide may act as a radioprotective agent in acromegaly.J Clin Endocrinol Metab85:1287–1289,2000
LandoltAM,,HallerD,,LomaxN,,ScheibS,,SchubigerO,&SiegfriedJ,et al.:Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.J Neurosurg88:1002–1008,1998
LeberKA,,BerglöffJ,&PendlG:Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery.J Neurosurg88:43–50,1998
LimYL,,LeemW,,KimTS,,RheeBA,&KimGK:Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery.Stereotact Funct Neurosurg70:1 Suppl95–109,1998
MelmedS,,VanceML,,BarkanAL,,BengtssonBA,,KleinbergD,&KlibanskiA,et al.:Current status and future opportunities for controlling acromegaly.Pituitary5:185–196,2002
OveR,,KelmanS,,AminPP,&ChinLS:Preservation of visual fields after perisellar gamma-knife radiosurgery.Int J Cancer90:343–350,2000
PollockBE,&CarpenterPC:Stereotactic radiosurgery as an alternative to fractionated radiation radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas.开云体育app官方网站下载入口53:1086–1094,2003
PollockBE,,NippoldtTB,,StaffordSL,,FooteRL,&AbboudCF:的结果stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization.J Neurosurg97:525–530,2002
PowellJS,,WardlawSL,,PostKD,&FredaPU:Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure.J Clin Endocrinol Metab85:2068–2071,2000
SheehanJP,,NiranjanA,,SheehanJM,,JaneJAJr,,LawsER,&KondziolkaD,et al.:Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium.J Neurosurg102:678–691,2005
ShimonI,,CohenZR,,RamZ,&HadaniM:Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.开云体育app官方网站下载入口48:1239–1245,2001
SimmonsNE,&LawsERJr:Glioma occurrence after sellar irradiation: case report and review.开云体育app官方网站下载入口42:172–178,1998
StaffordSL,,PollockBE,,LeavittJA,,FooteRL,,BrownPD,&GormanDA,et al.:A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery.Int J Radiat Oncol Biol Phys55:1177–1181,2003
TishlerRB,,LoefflerJS,,LunsfordLD,,DumaC,,AlexanderEIII,&KooyHM,et al.:Tolerance of cranial nerves of the cavernous sinus to radiosurgery.Int J Radiat Oncol Biol Phys27:215–221,1993
van LindertE,,HeyO,,Boecher-SchwarzH,&PerneczkyA:Treatment results of acromegaly as analyzed by different criteria.Acta Neurochir (Wien)139:905–913,1997
VladykaV,,LiscakR,,NovotnyJJr,,MarekJ,&JezkovaJ:Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas.开云体育app官方网站下载入口52:309–317,2003
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 2812 | 1309 | 45 |
Full Text Views | 217 | 21 | 1 |
PDF Downloads | 253 | 38 | 2 |
EPUB Downloads | 0 | 0 | 0 |